These differences in T cell phenotypes associated with their metabolic programs are in agreement with clinical observations showing that, T cells transduced with CD19.CAR-4-1BB.CD3ζ construct demonstrate superior efficacy in acute lymphoblastic leukemia than those transduced with the CD19.CAR-CD28.CD3ζ construct [66]. This evidence concerns the gene CD247 and acute lymphoblastic leukemia.